Cargando…

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance

BACKGROUND: Although significant advances have been made recently to characterize the biology of pancreatic ductal adenocarcinoma (PDAC), more efforts are needed to improve our understanding and to face challenges related to the aggressiveness, high mortality rate and chemoresistance of this disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaoutari, Abdessamad El, Fraunhoffer, Nicolas A, Hoare, Owen, Teyssedou, Carlos, Soubeyran, Philippe, Gayet, Odile, Roques, Julie, Lomberk, Gwen, Urrutia, Raul, Dusetti, Nelson, Iovanna, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054161/ https://www.ncbi.nlm.nih.gov/pubmed/33862584 http://dx.doi.org/10.1016/j.ebiom.2021.103332

Ejemplares similares

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers
por: El Kaoutari, Abdessamad, et al.
Publicado: (2023)

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019)

Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models
por: Hoare, Owen, et al.
Publicado: (2021)

Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
por: Gajate, Consuelo, et al.
Publicado: (2021)

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022)

Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosis
por: Santofimia-Castaño, Patricia, et al.
Publicado: (2018)

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
por: Mohamed Abd-El-Halim, Yousra, et al.
Publicado: (2021)

Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2023)

The promise of epigenomic therapeutics in pancreatic cancer
por: Lomberk, Gwen A, et al.
Publicado: (2016)

Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma
por: Santofimia-Castaño, Patricia, et al.
Publicado: (2019)

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool
por: Fraunhoffer, Nicolas A., et al.
Publicado: (2022)

Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma
por: Molejon, María Inés, et al.
Publicado: (2018)

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)
por: Bian, Benjamin, et al.
Publicado: (2019)

Single and combinatorial chromatin coupling events underlies the function of transcript factor krüppel-like factor 11 in the regulation of gene networks
por: Calvo, Ezequiel, et al.
Publicado: (2014)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2023)

Evidence supporting the existence of a NUPR1-like family of helix-loop-helix chromatin proteins related to, yet distinct from, AT hook-containing HMG proteins
por: Urrutia, Raul, et al.
Publicado: (2014)

Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
por: Masoud, Rawand, et al.
Publicado: (2020)

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53
por: Bonacci, Thomas, et al.
Publicado: (2014)

E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments
por: Lan, Wenjun, et al.
Publicado: (2018)

NUPR1 protects against hyperPARylation-dependent cell death
por: Santofimia-Castaño, Patricia, et al.
Publicado: (2022)

The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation
por: Loncle, C, et al.
Publicado: (2016)

Functional impact of Aurora A-mediated phosphorylation of HP1γ at serine 83 during cell cycle progression
por: Grzenda, Adrienne, et al.
Publicado: (2013)

The Heterochromatin Protein 1 family
por: Lomberk, Gwen, et al.
Publicado: (2006)

Functional characterization of EZH2β reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression
por: Grzenda, Adrienne, et al.
Publicado: (2013)

Pancreatitis promotes oncogenic Kras(G12D)-induced pancreatic transformation through activation of Nupr1
por: Grasso, Daniel, et al.
Publicado: (2014)

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
por: Nicolle, Rémy, et al.
Publicado: (2017)

Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma
por: Swayden, Mirna, et al.
Publicado: (2020)

Krüppel-like Factor 11 Differentially Couples to Histone Acetyltransferase and Histone Methyltransferase Chromatin Remodeling Pathways to Transcriptionally Regulate Dopamine D2 Receptor in Neuronal Cells
por: Seo, Seungmae, et al.
Publicado: (2012)

Mechanisms Underlying the Regulation of HP1γ by the NGF-PKA Signaling Pathway
por: Seo, Seungmae, et al.
Publicado: (2018)

Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
por: Bian, Benjamin, et al.
Publicado: (2017)

Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma
por: Huang, Can, et al.
Publicado: (2019)

Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss
por: Kalinec, Gilda M., et al.
Publicado: (2017)

Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation
por: Grasso, Daniel, et al.
Publicado: (2015)

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
por: Nicolle, Rémy, et al.
Publicado: (2020)

Silencing of the Transforming Growth Factor-β (TGFβ) Receptor II by Krüppel-like Factor 14 Underscores the Importance of a Negative Feedback Mechanism in TGFβ Signaling
por: Truty, Mark J., et al.
Publicado: (2009)

TNF-α induces endothelial–mesenchymal transition promoting stromal development of pancreatic adenocarcinoma
por: Adjuto-Saccone, Marjorie, et al.
Publicado: (2021)

Writers and readers of H3K9me2 form distinct protein networks during the cell cycle that include candidates for H3K9 mimicry
por: Pollin, Gareth, et al.
Publicado: (2023)

Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome
por: Juiz, Natalia Anahi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_chrh6gkt7qmppq6na5cafqc2es